InsidersTradesSigma
Follow the SeaSpine Holdings Corp share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, SeaSpine Holdings Corp has recorded 76 public disclosures. The latest transaction was disclosed on 9 January 2023 (Disposition). Among the most active insiders: BRADLEY KEITH. All data is openly available.
76
Insider Decl.
n/a
Thresholds
€126,749
1 ops.
Buy Volume
€833,470
22 ops.
Sell Volume
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 January 2023
Declarations76 total
23,725 sharesCommon StockSEC:0001637761-23-000045:0
82,654 sharesCommon StockSEC:0001637761-23-000041:0
23,993 sharesCommon StockSEC:0001637761-23-000044:0
460,275 sharesCommon StockSEC:0001637761-23-000039:0
102,563 sharesCommon StockSEC:0001637761-23-000032:0
88,592 sharesCommon StockSEC:0001637761-23-000040:0
111,966 sharesCommon StockSEC:0001637761-23-000042:0
333,797 sharesCommon StockSEC:0001637761-23-000031:0
69,628 sharesCommon StockSEC:0001637761-23-000035:0
128,640 sharesCommon StockSEC:0001637761-23-000046:0
20,950 sharesCommon StockSEC:0001637761-23-000033:0
90,951 sharesCommon StockSEC:0001637761-23-000038:0
48,556 sharesCommon StockSEC:0001637761-23-000034:0
131,284 sharesCommon StockSEC:0001637761-23-000036:0
36,056 sharesCommon StockSEC:0001637761-23-000043:0
4,868 sharesCommon StockSEC:0001637761-23-000014:0
5,575 sharesCommon StockSEC:0001637761-23-000009:0
5,280 sharesCommon StockSEC:0001637761-23-000012:0
12,183 sharesCommon StockSEC:0001637761-23-000008:0
5,352 sharesCommon StockSEC:0001637761-23-000011:0
1,041 sharesCommon StockSEC:0001637761-23-000010:0
8,362 sharesCommon StockSEC:0001637761-23-000013:0
1,320 shares@ US$4.9251.4% of flowCommon StockSEC:0001637761-22-000133:0
3,786 shares@ US$8.00100.0% of flowCommon StockSEC:0001637761-22-000134:0
2,500 shares@ US$4.9224.4% of flowCommon StockSEC:0001637761-22-000132:0
25 of 76 declarations
关于 SeaSpine Holdings Corp
SeaSpine Holdings Corp.（股票代码SPNE）是一家总部位于美国的医疗技术公司，在美国纳斯达克市场交易。在与Orthofix Medical Inc.合并之前，SeaSpine专注于脊柱外科，围绕脊柱疾病患者手术解决方案的设计、开发和商业化建立业务。该公司总部位于加利福尼亚州卡尔斯巴德，使其成为美国骨科和脊柱设备医疗技术关键集群之一。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1637761/000163776116000053/spne-2015123110xk.htm?utm_source=openai)) 从运营角度来看，SeaSpine开发了一个旨在覆盖脊柱外科价值链的产品组合。其产品包括脊柱植入物、生物制剂以及手术导航或程序支持工具。其商业模式旨在通过集成产品而非单一产品特许经营权服务外科医生、医院和专科护理机构。这使得SeaSpine成为一个要求严苛的细分市场中的专注参与者，在该市场中，临床采用、产品创新和外科医生关系对商业成功至关重要。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1637761/000163776116000053/spne-2015123110xk.htm?utm_source=openai)) 在竞争方面，SeaSpine在拥挤的全球脊柱和骨科医疗器械市场中运营，与规模更大的跨国制造商竞争。其战略利基市场是其在脊柱领域的专业化，以及将硬件、生物制剂和导航结合到更广泛的程序生态系统中的能力。对于投资者而言，这种类型的公司通常能带来程序增长和创新，但也意味着高执行风险、定价压力以及持续产品更新的需求。（[sec.gov](https://www.sec.gov/Archives/edgar/data/884624/000095017023019721/ofix-20230331.htm?utm_source=openai)) 最近最重要的公司事件是SeaSpine与Orthofix Medical Inc.的合并，该合并于2023年1月5日生效。美国证券交易委员会（SEC）文件显示，该交易是一项全股票对等合并，创建了一家更广泛的全球脊柱和骨科公司。作为该交易的一部分，SeaSpine股东获得了Orthofix股票，SeaSpine不再作为独立的上市公司运营。该期间的SEC Form 4文件也反映了与该交易相关的内部人持股变化。（[sec.gov](https://www.sec.gov/Archives/edgar/data/884624/000095017023019721/ofix-20230331.htm?utm_source=openai)) 对于法语投资者而言，关键信息是SeaSpine是一家在美国纳斯达克上市的医疗技术公司，拥有专业的脊柱特许经营权，总部位于加利福尼亚州卡尔斯巴德，专注于植入物、生物制剂和手术导航。其独立的股权故事随着2023年1月的合并而结束，此后其资产和业务并入Orthofix。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1637761/000163776116000053/spne-2015123110xk.htm?utm_source=openai))
